Product
B.63521
1 clinical trial
1 indication
Indication
HIVClinical trial
A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Ranging Doses of ALFQ Adjuvant in a Candidate HIV Vaccine Containing A244 and B.65321Status: Recruiting, Estimated PCD: 2023-10-23